Chen Bihua Insider Trading -- Recent SEC Form 4 Transactions

Chen Bihua (CIK 1599214) reported 28 SEC Form 4 insider transactions across 8 companies over the past 18 months (most recent 2026-08-10). Recent activity: Buy BLSM (1.6M shares), Buy BLSM (1.7M shares), Buy BLSM (312,500 shares), Sell BBOT (4.5M shares), Buy BBOT (2.7M shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-08-10BlossomHill Therapeutics, Inc. (BLSM)DirectorBuy1.6M$0
2026-08-10BlossomHill Therapeutics, Inc. (BLSM)DirectorBuy1.7M$0
2026-08-10BlossomHill Therapeutics, Inc. (BLSM)DirectorBuy312,500$5.0M
2026-07-06BridgeBio Oncology Therapeutics, Inc. (BBOT)DirectorSell4.5M$0
2026-07-06BridgeBio Oncology Therapeutics, Inc. (BBOT)DirectorBuy2.7M$0
2026-07-06BridgeBio Oncology Therapeutics, Inc. (BBOT)DirectorBuy1.7M$0
2026-07-06BridgeBio Oncology Therapeutics, Inc. (BBOT)DirectorBuy130,865$0
2026-04-30BRIGHT MINDS BIOSCIENCES INC. (DRUG)InsiderSell109,331$9.8M
2026-01-28Helix Acquisition Corp. III (HLXC)Chairperson and CEOBuy497,500$5.0M
2026-01-28Helix Acquisition Corp. III (HLXC)Chairperson and CEOBuy800,000$8.0M
2026-01-26Helix Acquisition Corp. III (HLXC)Chairperson and CEOBuy497,500$5.0M
2025-12-15Corbus Pharmaceuticals Holdings, Inc. (CRBP)10% OwnerSell30,029$344,132
2025-12-08EyePoint, Inc. (EYPT)InsiderSell60,000$942,000
2025-10-01MoonLake Immunotherapeutics (MLTX)InsiderSell2.8M$18.5M
2025-10-01MoonLake Immunotherapeutics (MLTX)InsiderSell232,460$2.0M
2025-10-01MoonLake Immunotherapeutics (MLTX)InsiderSell3.4M$25.7M
2025-10-01MoonLake Immunotherapeutics (MLTX)InsiderSell70,748$663,616
2025-10-01MoonLake Immunotherapeutics (MLTX)InsiderSell5,827$40,556
2025-08-13BridgeBio Oncology Therapeutics, Inc. (BBOT)DirectorBuy4.2M$0
2025-08-13BridgeBio Oncology Therapeutics, Inc. (BBOT)DirectorSell152,940$0
2025-08-13BridgeBio Oncology Therapeutics, Inc. (BBOT)DirectorBuy760,496$8.2M
2025-08-13BridgeBio Oncology Therapeutics, Inc. (BBOT)DirectorBuy639,110$6.9M
2025-08-13BridgeBio Oncology Therapeutics, Inc. (BBOT)DirectorBuy5.6M$60.0M
2025-08-13BridgeBio Oncology Therapeutics, Inc. (BBOT)DirectorBuy1.9M$0
2025-08-13BridgeBio Oncology Therapeutics, Inc. (BBOT)DirectorBuy1.8M$0

Source: SEC Form 4 filings · as of 2026-08-10